NeoMedix Offers Innovative Minimally Invasive Glaucoma Surgery

And it states that it is virtually pain free...FDA approved...visit the website for additional information...BD

Glaucoma is a devastating disease that harms the eye without manifesting early signs or symptoms. Since people can have glaucoma and not even know it, this disorder has been called "the silent thief of sight." Glaucoma is a leading cause of blindness and vision impairment affecting approximately 3 million Americans, and 69 million people worldwide.

Trabectome(R) is a minimally invasive procedure. Developed by NeoMedix of Tustin, California, this FDA-cleared device typically reduces intra-ocular pressure (IOP) without the aid of mechanical implants or shunts. By gently removing a portion of the patient's clogged tissue (the trabecular meshwork) Trabectome re-establishes access to the eye's natural drainage pathway.